CONMED (CNMD)
(Delayed Data from NYSE)
$71.31 USD
-1.30 (-1.79%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $71.31 0.00 (0.00%) 7:14 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Price, Consensus and EPS Surprise
CNMD 71.31 -1.30(-1.79%)
Will CNMD be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CNMD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CNMD
Smith+Nephew (SNN) Expands in Australia With New Alliance
Here's Why You Should Retain CONMED (CNMD) Stock for Now
CNMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Retain CONMED (CNMD) Stock for Now
CONMED (CNMD) Misses on Q4 Earnings, Beats Revenue Estimates
Here's What Key Metrics Tell Us About Conmed (CNMD) Q4 Earnings
Other News for CNMD
Interesting CNMD Put And Call Options For June 21st
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Analysts Conflicted on These Healthcare Names: Conmed (CNMD), AbbVie (ABBV) and Nurix Therapeutics (NRIX)
ClearBridge Small Cap Growth Strategy Q2 2024 Portfolio Manager Commentary
CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024